| Oct 16 |
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
|
| Oct 16 |
JAZZ Stock Soars After Combo Therapy Meets Goal in Lung Cancer Study
|
| Oct 16 |
Is Jazz Pharmaceuticals (JAZZ) the Best Small-Cap Value Stock to Buy According to Hedge Funds?
|
| Oct 16 |
Jazz Pharmaceuticals: Unexpected Wins Improve The Long-Term Outlook
|
| Oct 16 |
Jazz Pharmaceuticals’ Zepzelca combination meets endpoints in lung cancer trial
|
| Oct 15 |
Jazz Pharma gains on late-stage trial win for cancer drug
|
| Oct 15 |
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
|
| Oct 15 |
PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
|
| Oct 15 |
Jazz Pharmaceuticals Announces Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
|
| Oct 15 |
Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data
|
